PreCardix is clinically proven to lower blood pressure safely and effectively

PreCardix is the result of over a decade of blood pressure research and clinical study dedicated to finding an effective, sustainable and proven natural blood pressure solution.

Clinical Trial Highlights
  • 89% of clinical trial participants experienced a significant blood pressure lowering effect within 8 weeks
  • 69% of clinical trial participants reduced their blood pressure by over 10mmHg in 8 weeks
  • 24% of clinical trial participants reduced their blood pressure by over 15mmHg within 8 weeks

Clinical Trial Details

Two clinical studies Marealis 13TBHM and Mare-study were conducted on PreCardix between 2012 and 2015 with over two hundred and twenty male and female participants ages 30 - 75. Clinical results show that the bioactive marine peptides in PreCardix have a natural ACE inhibiting effect on the body resulting in a significant blood pressure reduction in over 89% of participants within eight weeks or less.

89% experienced a significant blood pressure lowering effect in 8 weeks.

Study

The PreCardix peer-reviewed clinical study has been published by the International Journal of Hypertension. A Randomized, Double-Blind, Placebo-Controlled, Multicentre Trial of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure.